156 FIFTH AVENUE 10TH FLOOR, NEW YORK, NY
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Nexentis Technologies Enters $2.9 Million Securities Purchase Agreement
Nexentis Technologies Inc. Enters Into Securities Purchase Agreement
Nexentis Technologies Enters Material Definitive Agreement with L.I.A. Pure C...
Stockholders Approve Reverse Stock Split for Nexentis Technologies Inc.
Completion of Acquisition - Nexentis Technologies Transfers Shares to Voice A...
Unregistered Sales of Equity Securities
Announcing Corporate Rebranding as Nexentis Technologies - Innovative AI and Data Driven Computational Biotech Company
Q2
Q1
FY 2025
Q3
FY 2024
Effectiveness Notice
S-1
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(3)
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Post-Effective Amendment to Registration Statement
Correspondence
Submission Upload
PREM14A